Global Breast Biopsy Market, 2020-2026
A breast biopsy is a simple medical procedure in which a sample of breast tissue is removed and sent to a laboratory for testing. The procedure is less invasive than surgical biopsy, leaves little or no scarring and can be performed in less than an hour. According to Gen Consulting Company, global breast biopsy market is projected to grow at a CAGR of 5.5% during the forecast period 2020-2026.
The report offers a breakdown of market shares by product, including Vacuum-Assisted Biopsy (VAB), Core-Needle Biopsy (CNB), Fine-Needle Aspiration Biopsy (FNAB). Based on end use, the market for breast biopsy is segmented into Diagnostic Centers, Hospitals. By technology, the breast biopsy market is classified into MRI-Guided Biopsy, Ultrasound-Guided Biopsy, Mammography-Guided Stereotactic Biopsy, CT-Guided Biopsy. On the basis of region, the breast biopsy industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).
By Product:
The base year of the study is 2019, and forecasts run up to 2026.
Research Objective
The report offers a breakdown of market shares by product, including Vacuum-Assisted Biopsy (VAB), Core-Needle Biopsy (CNB), Fine-Needle Aspiration Biopsy (FNAB). Based on end use, the market for breast biopsy is segmented into Diagnostic Centers, Hospitals. By technology, the breast biopsy market is classified into MRI-Guided Biopsy, Ultrasound-Guided Biopsy, Mammography-Guided Stereotactic Biopsy, CT-Guided Biopsy. On the basis of region, the breast biopsy industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).
By Product:
- Vacuum-Assisted Biopsy (VAB)
- Core-Needle Biopsy (CNB)
- Fine-Needle Aspiration Biopsy (FNAB)
- Diagnostic Centers
- Hospitals
- MRI-Guided Biopsy
- Ultrasound-Guided Biopsy
- Mammography-Guided Stereotactic Biopsy
- CT-Guided Biopsy
- North America (U.S., Canada, Mexico, etc.)
- Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
- Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
- Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
- South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)
- Argon Medical Devices, Inc.
- Becton and Dickinson Company
- C. R. Bard, Inc.
- Cook Medical Incorporated
- Danaher Corporation (Leica Biosystems)
- Encapsule Medical Devices, LLC
- Ethicon Inc.
- Hologic Inc.
- Intact Medical Corporation
The base year of the study is 2019, and forecasts run up to 2026.
Research Objective
- To analyze and forecast the market size of global breast biopsy market.
- To classify and forecast global breast biopsy market based on product, end use, technology.
- To identify drivers and challenges for global breast biopsy market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global breast biopsy market.
- To conduct pricing analysis for global breast biopsy market.
- To identify and analyze the profile of leading players operating in global breast biopsy market.
- Manufacturers of breast biopsy
- Raw material suppliers
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to breast biopsy
PART 1. INTRODUCTION
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
PART 2. METHODOLOGY
2.1 Primary
2.2 Secondary
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Consumers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitute Products and Services
4.5.5 Degree of Competition
PART 5. GLOBAL MARKET FOR BREAST BIOPSY BY PRODUCT
5.1 Market Overview
5.2 Vacuum-Assisted Biopsy (VAB)
5.2.1 Market Size and Forecast
5.3 Core-Needle Biopsy (CNB)
5.3.1 Market Size and Forecast
5.4 Fine-Needle Aspiration Biopsy (FNAB)
5.4.1 Market Size and Forecast
PART 6. GLOBAL MARKET FOR BREAST BIOPSY BY END USE
6.1 Market Overview
6.2 Diagnostic Centers
6.2.1 Market Size and Forecast
6.3 Hospitals
6.3.1 Market Size and Forecast
PART 7. GLOBAL MARKET FOR BREAST BIOPSY BY TECHNOLOGY
7.1 Market Overview
7.2 MRI-Guided Biopsy
7.2.1 Market Size and Forecast
7.3 Ultrasound-Guided Biopsy
7.3.1 Market Size and Forecast
7.4 Mammography-Guided Stereotactic Biopsy
7.4.1 Market Size and Forecast
7.5 CT-Guided Biopsy
7.5.1 Market Size and Forecast
PART 8. GLOBAL MARKET FOR BREAST BIOPSY BY GEOGRAPHY
8.1 Overview
8.1.1 Market Size and Forecast
8.2 North America
8.2.1 Market Size and Forecast
8.2.2 North America: Breast Biopsy Market by Country
8.2.2.1 United States
8.2.2.2 Canada
8.2.2.3 Mexico
8.3 Europe
8.3.1 Market Size and Forecast
8.3.2 Europe: Breast Biopsy Market by Country
8.3.2.1 Germany
8.3.2.2 France
8.3.2.3 United Kingdom
8.3.2.4 Italy
8.3.2.5 Rest of The Europe
8.4 Asia-Pacific
8.4.1 Market Size and Forecast
8.4.2 Asia-Pacific: Breast Biopsy Market by Country
8.4.2.1 China
8.4.2.2 India
8.4.2.3 Japan
8.4.2.4 South Korea
8.4.2.5 ASEAN Countries
8.5 Middle East and Africa (MEA)
8.5.1 Market Size and Forecast
8.5.2 MEA: Breast Biopsy Market by Country
8.5.2.1 Saudi Arabia
8.5.2.2 South Africa
8.5.2.3 Turkey
8.6 South America
8.6.1 Market Size and Forecast
8.6.2 South America: Breast Biopsy Market by Country
8.6.2.1 Brazil
8.6.2.2 Argentina
8.6.2.3 Rest of South America
PART 9. COMPETITIVE LANDSCAPE
9.1 Market Share
9.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships
PART 10. KEY COMPETITOR PROFILES
10.1 Argon Medical Devices, Inc.
10.2 Becton and Dickinson Company
10.3 C. R. Bard, Inc.
10.4 Cook Medical Incorporated
10.5 Danaher Corporation (Leica Biosystems)
10.6 Encapsule Medical Devices, LLC
10.7 Ethicon Inc.
10.8 Hologic Inc.
10.9 Intact Medical Corporation
*LIST IS NOT EXHAUSTIVE
PART 11. PATENT ANALYSIS
11.1 Patent Statistics
11.2 Regional Analysis
11.3 Trends Analysis
DISCLAIMER
ABOUT GEN CONSULTING COMPANY
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
PART 2. METHODOLOGY
2.1 Primary
2.2 Secondary
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Consumers
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitute Products and Services
4.5.5 Degree of Competition
PART 5. GLOBAL MARKET FOR BREAST BIOPSY BY PRODUCT
5.1 Market Overview
5.2 Vacuum-Assisted Biopsy (VAB)
5.2.1 Market Size and Forecast
5.3 Core-Needle Biopsy (CNB)
5.3.1 Market Size and Forecast
5.4 Fine-Needle Aspiration Biopsy (FNAB)
5.4.1 Market Size and Forecast
PART 6. GLOBAL MARKET FOR BREAST BIOPSY BY END USE
6.1 Market Overview
6.2 Diagnostic Centers
6.2.1 Market Size and Forecast
6.3 Hospitals
6.3.1 Market Size and Forecast
PART 7. GLOBAL MARKET FOR BREAST BIOPSY BY TECHNOLOGY
7.1 Market Overview
7.2 MRI-Guided Biopsy
7.2.1 Market Size and Forecast
7.3 Ultrasound-Guided Biopsy
7.3.1 Market Size and Forecast
7.4 Mammography-Guided Stereotactic Biopsy
7.4.1 Market Size and Forecast
7.5 CT-Guided Biopsy
7.5.1 Market Size and Forecast
PART 8. GLOBAL MARKET FOR BREAST BIOPSY BY GEOGRAPHY
8.1 Overview
8.1.1 Market Size and Forecast
8.2 North America
8.2.1 Market Size and Forecast
8.2.2 North America: Breast Biopsy Market by Country
8.2.2.1 United States
8.2.2.2 Canada
8.2.2.3 Mexico
8.3 Europe
8.3.1 Market Size and Forecast
8.3.2 Europe: Breast Biopsy Market by Country
8.3.2.1 Germany
8.3.2.2 France
8.3.2.3 United Kingdom
8.3.2.4 Italy
8.3.2.5 Rest of The Europe
8.4 Asia-Pacific
8.4.1 Market Size and Forecast
8.4.2 Asia-Pacific: Breast Biopsy Market by Country
8.4.2.1 China
8.4.2.2 India
8.4.2.3 Japan
8.4.2.4 South Korea
8.4.2.5 ASEAN Countries
8.5 Middle East and Africa (MEA)
8.5.1 Market Size and Forecast
8.5.2 MEA: Breast Biopsy Market by Country
8.5.2.1 Saudi Arabia
8.5.2.2 South Africa
8.5.2.3 Turkey
8.6 South America
8.6.1 Market Size and Forecast
8.6.2 South America: Breast Biopsy Market by Country
8.6.2.1 Brazil
8.6.2.2 Argentina
8.6.2.3 Rest of South America
PART 9. COMPETITIVE LANDSCAPE
9.1 Market Share
9.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships
PART 10. KEY COMPETITOR PROFILES
10.1 Argon Medical Devices, Inc.
10.2 Becton and Dickinson Company
10.3 C. R. Bard, Inc.
10.4 Cook Medical Incorporated
10.5 Danaher Corporation (Leica Biosystems)
10.6 Encapsule Medical Devices, LLC
10.7 Ethicon Inc.
10.8 Hologic Inc.
10.9 Intact Medical Corporation
*LIST IS NOT EXHAUSTIVE
PART 11. PATENT ANALYSIS
11.1 Patent Statistics
11.2 Regional Analysis
11.3 Trends Analysis
DISCLAIMER
ABOUT GEN CONSULTING COMPANY